chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient noted to have a rash under arms and an achy, sore armpit with swollen lymph glands approximately 8 days post vaccine.
Aches; Diarrhea; Injection site Hot; Delayed injection site reaction; Injection site redness; Injection site swollen; Injection site tender; Headaches; This spontaneous case was reported by a physician assistant and describes the occurrence of PAIN (Aches), DIARRHOEA (Diarrhea), VACCINATION SITE WARMTH (Injection site Hot), SKIN REACTION (Delayed injection site reaction) and VACCINATION SITE ERYTHEMA (Injection site redness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Aches), DIARRHOEA (Diarrhea), VACCINATION SITE WARMTH (Injection site Hot), SKIN REACTION (Delayed injection site reaction), VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE SWELLING (Injection site swollen), VACCINATION SITE PAIN (Injection site tender) and HEADACHE (Headaches). At the time of the report, PAIN (Aches), DIARRHOEA (Diarrhea), VACCINATION SITE WARMTH (Injection site Hot), SKIN REACTION (Delayed injection site reaction), VACCINATION SITE ERYTHEMA (Injection site redness), VACCINATION SITE SWELLING (Injection site swollen), VACCINATION SITE PAIN (Injection site tender) and HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Symptoms began with the chills but no fever eight hours after my second injection. I woke up the next day (Monday, January 18) with a raging migraine that lasted until Wednesday, January 20. I began vomiting at 11:00 am on January 18 for the next 14 1/2 hours. I could not hold any food or even water down until the evening of January 19. I had to call in sick on the 19th. I went to work on the 20th once the migraine subsided and vomiting ended the evening before around 9:00 pm. All symptoms disappeared by late morning of January 20.
sore arm; headache that started at night; nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm), HEADACHE (headache that started at night), NAUSEA (nausea) and VOMITING (Vomiting) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 025J20A) for COVID-19 vaccination.     No medical history information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm), NAUSEA (nausea) and VOMITING (Vomiting). 08-Feb-2021, the patient experienced HEADACHE (headache that started at night). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at a dose of 325 milligram and BISMUTH SUBSALICYLATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE]) at a dose of 262 milligram. At the time of the report, VACCINATION SITE PAIN (sore arm), NAUSEA (nausea) and VOMITING (Vomiting) was resolving and HEADACHE (headache that started at night) had not resolved.            No concomitant drugs were reported.  Action taken with mRNA-1273 in response to the events was not applicable.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report was received from a Licensed Practical Nurse regarding an unspecified number of patients of unknown demographics. There was no information about concurrent condition and historical medication. On an unknown date the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX. No adverse event was reported. No concomitant medications were reported. The outcome of event was unknown. Temperature was maximum -3.5 C, time frame was no more than 1 hour every night (defrost cycling) and there was no Previous temperature excursion. Call was because of a data logger. MMR II appears in the Product List as it was involved in the excursion, however no improperly stored doses were administered. This is one of several reports received from the same reporter. Additional information has been requested.
Pt called this morning around 7/29, 11 AM. She woke up the previous night when she turned on her side while sleeping. She noticed that the shoulder where the vaccine was administered developed a bumpy rash. The site still had the band-aid on it. The rash was itchy, and she asked if it was ok to put anti-itch cream on it. I advised her to monitor the rash and to take hydrocortisone cream and benadryl if needed. I confirmed that the band-aid was not made of latex, so the band-aid allergy is not likely.
The patient reports that a couple of minutes after receiving the shot her left "shoulder/arm" was very painful.  This pain has remained "excruciating" when her arm is in motion after two weeks, although it is not as painful when not in motion as it was initially.  There was not a local reaction noted at the site of injection.  The patient saw the physician's assistant at her regular physician's office on October 16, 2008, ten days after the shot, and she was prescribed Mobic/Meloxicam for the pain, which does help.  She has had an xray subsequently, but does not have the result.  She may be referred to an orthopedic specialist if the pain continues to bother her.  She states that she has not previously had problems with flu shots.
LOW GRADE FEVER; BODY ACHES; CHILLS; This spontaneous report received from a patient concerned female of unspecified age.. The patient's height, and weight were not reported. The patient's past medical history included fibromyalgia, heart disease, heart attack, hip surgery, gall bladder removed, and angioplasty, and concurrent conditions included cigarette smoker, sulfa allergy, penicillin allergy, and abstains from alcohol, and other pre-existing medical conditions included patient had no drug abuse or illicit drug usage.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802068, and expiry: not reported) .5 ml, administered on 10-MAR-2021 to Right Arm for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, the subject experienced low grade fever. On 10-MAR-2021, the subject experienced body aches. On 10-MAR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from low grade fever, body aches, and chills. This report was non-serious.
pt recvd vax 8MAR93 & on 10MAY93 a BC revealed Haemophilus influenzae type b infection; addtl details are being requested;
Fever of 100.1 degrees; Chills; Body aches; General sleepiness; Swelling of the eyelids; Asthmatic wheezing; Shortness of breath; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 14Aug2021 at 08:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included unspecified allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 15Aug2021 at 03:00, the patient experienced fever of 100.1 degrees, chills, body aches for 24 hours and general sleepiness. On the same day, the patient also experienced swelling of the eyelids, asthmatic wheezing and shortness of breath lasting for 48 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events fever of 100.1 degrees, chills, and body aches were resolved on 16Aug2021 at 03:00 (after the duration of 24 hours). The clinical outcome of the event general sleepiness was resolved on an unknown date in 2021; while that of the events swelling of the eyelids, asthmatic wheezing and shortness of breath were resolved on 17Aug2021 at 03:00 (after the duration of 48 hours).
Began experiencing chest pains and shortness of breath 2 weeks after the second shot. Pain became intolerable and was alarming so I made appointment with my primary care physician. The EKG was abnormal so a CT scan was ordered.  The discomfort continued for 2 days until pains grew extreme and had to go to the ER. Was admitted for 5 days and was told I had a miocardial infarction after a series of tests. A catheter procedure was done to place a stent in my LAD artery which was 90 percent blocked.
Patient stated when interviewed for positive case that she received vaccine and in april she was in the hospital and diagnosed with guillen barrie and they think it is from the vaccine.
After my fourth day (March 16th) of the vaccine this is what happened:  Day started great and about 1pm started having severe diarrhea with intervals of 15 to 30 minutes apart. At approximately 2:30pm I started having projectile vomiting. All of this lasted until approximately 5pm, I was also very clammy and cold, no fever. by 7pm I felt somewhat normal.  The next day I felt great!  It was an experience I've never had before so that why I am sending this to you!
1 month following 2nd shot of Moderna i developed a shingles like rash on my Right shoulder/arm it lasted a couple of weeks
headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 23Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 24Apr2021, outcome "unknown", described as "headache".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Headache, Fever, NauseaVomiting, Increased fatigue, intense muscle achiness, 'brain fog'- severe migraine Narrative:
Received first SHINGRIX shot 01/22/2019 about 12:00 noon, administered by PCP. On the morning of 01/23/2019, BP 141/76 P 101, before taking BENICAR 20mg. At 11:40 felt weak, sweating, dizzy, pale - BP 75/44 P51. After consuming 12oz water, 5.5oz V-8 (450mg sodium), half an orange, at 11:50 BP 139/78 P 76. Saw PCP on 01/23/2019 at 1:00pm, BP 124/68 P84, temperature 99, EKG normal. The occurrence of the Bradycardia event is an anomaly, the only variable being the SHINGRIX shot.
Swollen bottom lip; Burning bottom lip; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Swollen bottom lip) and ORAL DISCOMFORT (Burning bottom lip) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jul-2021, the patient experienced LIP SWELLING (Swollen bottom lip) and ORAL DISCOMFORT (Burning bottom lip). At the time of the report, LIP SWELLING (Swollen bottom lip) and ORAL DISCOMFORT (Burning bottom lip) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Products known to have been used by the patient, within two weeks prior to the event, included Blood pressure medicines.  Treatment information was not provided. Patient reported that after 30 to 45 minutes of vaccination, adverse events started and felt like it was still getting bigger.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow- up  received contains non significant information. Outcome of the events and onset time updated in narrative from the initial source.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Within 24 hrs from  1st vaccine :Low grade fever ,  chills , aches  Within 2 weeks from 1st vaccine - . multi system inflammation since vaccine ( intestinal, sinus) , dizziness , chills on off , episode of heart palpitations not occurring prior to vaccine
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. Nurse reported that an unspecified number of doses of VAQTA (single dose, route and lot number were not reported) were administered to patients on unspecified dates after a supported excursion of 20C over a period of 15 hours. No adverse  events were reported. This case is linked to cases 1403USA001475, 1403USA002926, 1403USA002928 and 1403USA002929 via same reporter link. Additional information has been requested.
pain, dec ambulation rt hip; no temp; mild URI x 3d; onset 11NOV; recvd vax 10NOV;
postherpetic neuralgia; herpes zoster; varicella type rash; Information was received from a lawyer regarding a case in litigation involving a female patient of unknown age. On 03-DEC-2014, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot # and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date, shortly after receiving the vaccine the patient was diagnosed with herpes zoster, postherpetic neuralgia and a varicella type rash. As a direct and proximate result of receiving zoster vaccine live (ZOSTAVAX) the patients symptoms have resulted in physical limitations not present prior to using the product. She also experienced mental and emotional distress due to resulting physical limitations and seriousness of condition. As a result of zoster vaccine live (ZOSTAVAX) the patient suffered severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury.As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.The outcome of the events was considered to be not recovered. The causality of the events was considered to be related. The events were considered to be disabling.
Fever to 102 for 2-3 days after Hep A #1 - onset within hours after vaccination, no other signs/symptoms of illness.
After the flu and pneumonia shots my arm started to hurt, I became VERY nauseous, developed painful headache, mild fever, pain from my arm spread through my head, neck, back, and joints, and the pain increase throughout the next 24 hours and did not subside until after 48 hours. I could not get out of bed on 12/10/2012 and had to stay home from work again on 12/11/2012. I would have gone to the doctors on 12/10/2012 if I wasn't so sick!
Approximately 48 hours after administration, patient experienced erythema, swelling and itchiness at injection site. Symptoms have since subsided without any treatment necessary.
4/21/21 - injection site very red and swollen.  arm hurts even when it is not being touched. Lasted all day. 4/22 and 4/23 - injection site still red but only hurts when touched. Injection site now has a hard knot about the size of a half dollar.
She got her vaccine, does not remember anything other than a sore arm or a bad reaction itself at the time.  About 2 weeks later when she returned home she noticed that her head was really itchy and burning.  Her ear got real red, inflamed and hurt.  She went to the ER and he asked her if she had had shingles before and dismissed it.  He said that she had cellulitis.  She went to her message therapist who informed her that she had shingles.  She did not take anything for the reaction other than her vitamins and Tylenol.  The nodules went away in about 3-4 weeks.  She occasionally has a little ache on her scalp, kind of an aftermath of it.  They were mainly on the left side of her scalp
Dry Cough, swollen reddish left arm after 2 days of receiving the vaccination.
Rash (around the injection site); Swelling (around the injection site); Redness (around the injection site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash (around the injection site)), VACCINATION SITE SWELLING (Swelling (around the injection site)) and VACCINATION SITE ERYTHEMA (Redness (around the injection site)) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash (around the injection site)), VACCINATION SITE SWELLING (Swelling (around the injection site)) and VACCINATION SITE ERYTHEMA (Redness (around the injection site)). At the time of the report, VACCINATION SITE RASH (Rash (around the injection site)), VACCINATION SITE SWELLING (Swelling (around the injection site)) and VACCINATION SITE ERYTHEMA (Redness (around the injection site)) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant details were provided No treatment details were provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
low grade fever; diagnosed with shingles; skin pain; pain at the injection site; red rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (diagnosed with shingles), PAIN OF SKIN (skin pain), VACCINATION SITE PAIN (pain at the injection site), VACCINATION SITE RASH (red rash around the injection site) and PYREXIA (low grade fever) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included GABAPENTIN, LEVOTHYROXINE, PANTOPRAZOLE, LAMOTRIGINE, ACETYLSALICYLIC ACID (ASPIRIN CUPAL [ACETYLSALICYLIC ACID]) and PAROXETINE for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site) and VACCINATION SITE RASH (red rash around the injection site). On 15-Feb-2021, the patient experienced PAIN OF SKIN (skin pain). On 18-Feb-2021, the patient experienced HERPES ZOSTER (diagnosed with shingles). On 23-Feb-2021, the patient experienced PYREXIA (low grade fever). The patient was treated with ACETAMINOPHEN in February 2021 for Adverse reaction, at an unspecified dose and frequency. On 25-Feb-2021, PYREXIA (low grade fever) had resolved. At the time of the report, HERPES ZOSTER (diagnosed with shingles), PAIN OF SKIN (skin pain), VACCINATION SITE PAIN (pain at the injection site) and VACCINATION SITE RASH (red rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was also reported that the shingles appeared on the same side of the body where the vaccine was administered.  Patient was treated with unspecified antiviral medication for Shingles starting on 19-FEB-2021.
Swelling, redness, itching, low grade fever. Pt applied hydrocortisone cream, aloe vera, ice, and took acetaminophen.
The injection hurt significantly as it was given through a band aid. I had bruising on my arm and pain for several days. Now my arm is still sore and my range of motion using that shoulder is limited and quite painful with reaching movements.  My voice began to be affected with hoarseness and at times it has been difficult to talk. My voice still squeaks and I can?t get volume as I speak. I understand I was given high dose vaccine grown on eggs. This is the only time I? e had a reaction following a flu shot.
Admit 8/1/2021:  Exposure to someone with COVID 6 days prior. Breakthrough COVID  and acute hypoxic respiratory failure secondary to COVID-19. first Pfizer given 3/6/2021 Lot ER8730 second 4/6/2021 EW0171